Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months
Open Access
- 4 August 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Oncology and Therapy
- Vol. 8 (2), 171-182
- https://doi.org/10.1007/s40487-020-00124-2
Abstract
The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact on patients with underlying malignancy. In this article, we summarize emerging data related to patients with cancer and COVID-19. Among patients with COVID-19, a higher proportion have an underlying diagnosis of cancer than seen in the general population. Also, patients with malignancy are likely to be more vulnerable than the general population to contracting COVID-19. Mortality is significantly higher in patients with both cancer and COVID-19 compared with the overall COVID-19-positive population. The early months of the pandemic saw a decrease in cancer screening and diagnosis, as well as postponement of standard treatments, which could lead to excess deaths from cancer in the future.This publication has 78 references indexed in Scilit:
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, ChinaJAMA Oncology, 2020
- Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for FatalityEmerging Infectious Diseases, 2020
- Critical Care Utilization for the COVID-19 Outbreak in Lombardy, ItalyJAMA, 2020
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in ItalyJAMA, 2020
- Diversity in biology: definitions, quantification and modelsPhysical Biology, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Telehealth models could be extended to conducting clinical trials-a teletrial approachEuropean Journal of Cancer Care, 2016
- Community acquired respiratory virus infections in cancer patients—Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical OncologyEuropean Journal of Cancer, 2016
- Lymphocyte depletion and repopulation after chemotherapy for primary breast cancerBreast Cancer Research, 2016
- Infections in Patients with Leukemia and LymphomaCancer Treatment and Research, 2014